A BRD4-GATA4 module cooperatively regulates mitochondrial bioenergetic homeostasis in the adult heart
BRD4-GATA4 模块协同调节成人心脏中的线粒体生物能稳态
基本信息
- 批准号:10372139
- 负责人:
- 金额:$ 15.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAcuteAddressAdultAffectAmericanAnimal ModelAreaBRD2 geneBindingBiochemicalBioenergeticsBioinformaticsBiological AssayBiologyBromodomainCardiacCardiac MyocytesCardiologyCardiovascular DiseasesCardiovascular ModelsCardiovascular systemCell modelCellsChIP-seqChromatinClinicalCommunicationComplexCoupledDataDevelopmentDevelopment PlansDevelopmental BiologyDiagnosisDiseaseDisease modelDown-RegulationElementsEnergy MetabolismEnhancersEnvironmentEpigenetic ProcessEquipmentFamilyFundingGATA4 geneGene ExpressionGene Expression RegulationGenesGenetic TranscriptionGoalsHeartHeart failureHomeostasisIn VitroInstitutesK-Series Research Career ProgramsKnowledgeLaboratoriesLeadLysineMacromolecular ComplexesMapsMediatingMentorsMentorshipMetabolicMitochondriaModelingMolecularMolecular BiologyMusMutationNeurohormonesNodalOxidative PhosphorylationPathogenesisPersonsPhasePhenotypePhysiciansProcessProteinsQuality of lifeReaderRegulationRegulator GenesRegulatory ElementResearchResearch PersonnelResearch TrainingRodentRoleRunningSchemeScientistSeriesSpecificityTechniquesTertiary Protein StructureTestingTherapeutic EffectTissuesTrainingUnited StatesWorkbasecareercareer developmentcostdefined contributiondesignexperienceheart functionheart metabolismin vivoinhibitorinsightinterestmembermitochondrial dysfunctionmitochondrial metabolismmortalitymouse modelmutantnovelnovel therapeutic interventionnovel therapeuticspreservationprogramsprotein complexprotein functionreconstitutionrecruitscaffoldskillssmall moleculestandard of carestemtherapeutic targettranscription factortranscriptome sequencing
项目摘要
PROJECT SUMMARY / ABSTRACT
Heart failure (HF) affects millions of people and costs over 40 billion dollars annually in the United States
alone. Despite current pharmacotherapeutic approaches, which largely involve blockade of circulating
neurohormone activity, a diagnosis of HF carries a 5‐year mortality rate of nearly 50% underscoring the urgent
need for new treatments. The mitochondria have emerged as a central factor in the pathogenesis and
progression of HF with no therapies presently available to address mitochondrial dysfunction.
My goal in seeking a K08 Mentored Clinical Scientist Research Career Development Award is to acquire
the necessary knowledge and practical training to make major advances in our understanding of the
mechanisms underlying cardiac energy metabolism and mitochondrial function in the adult heart. I hypothesize
that BRD4 (a ubiquitously expressed chromatin “reader” protein) complexes with GATA4 (a lineage
determining cardiac transcription factor) to regulate a mitochondrial bioenergetic gene program in
cardiomyocytes (Aim 1). I also hypothesize that GATA4 is a critical regulator of cardiac metabolism in
cardiomyocytes in vivo and that this tissue-enriched transcription factor is providing specificity to the action of
BRD4 (Aim 2). Finally, I hypothesize that a BRD4-GATA4 module controls the expression of PGC-1α and β,
known master transcriptional regulators of mitochondrial genes, to mediate the phenotype of cardiomyocyte
BRD4 loss (Aim 3). To address these aims, I will combine novel animal models that I have generated, standard
in vitro biochemical approaches, and advanced molecular biology and bioinformatics techniques. My long-term
goal is to develop a deeper molecular understanding of HF pathogenesis that may lead to novel therapies.
My graduate training provided me with important experience in cardiovascular research, however my focus
was on developmental biology. I am now directing my efforts towards studying adult cardiomyocyte
homeostasis—an area of interest that emerged from my clinical training in cardiology. My research mentor has
a long record of impactful discoveries using cutting-edge techniques in cellular and animal models of
cardiovascular disease. The research environment at the Gladstone Institutes/UCSF is exceptional and houses
state-of-the-art equipment and investigators making groundbreaking discoveries. I have assembled a team of
highly accomplished mentors and advisors to guide me through this next phase of my training on the path to
becoming an independent investigator. My training plan is specifically designed to provide me with mentorship
and research training in bioinformatics, mouse modeling of disease, and advanced techniques in molecular
biology. Beyond this, I will gain experience with other skills required to run a research group, such as scientific
communication and laboratory management. Completing the research and obtaining the skill sets outlined in
this proposal will prepare me well to obtain R01 or equivalent funding to begin my career as an independent
investigator.
项目概要/摘要
在美国,心力衰竭 (HF) 影响数百万人,每年造成的损失超过 400 亿美元
独自的。尽管目前的药物治疗方法主要涉及阻断循环
神经激素活性,心力衰竭的诊断导致 5 年死亡率接近 50%,这凸显了紧急情况
需要新的治疗方法。线粒体已成为发病机制中的核心因素,
目前尚无可用于解决线粒体功能障碍的治疗方法。
我寻求 K08 指导临床科学家研究职业发展奖的目标是获得
必要的知识和实践培训,以在我们对事物的理解上取得重大进展
成人心脏中心脏能量代谢和线粒体功能的潜在机制。我假设
BRD4(一种普遍表达的染色质“阅读器”蛋白)与 GATA4(一种谱系
确定心脏转录因子)来调节线粒体生物能基因程序
心肌细胞(目标 1)。我还假设 GATA4 是心脏代谢的关键调节因子
体内心肌细胞,这种富含组织的转录因子为心肌细胞的作用提供了特异性
BRD4(目标 2)。最后,我假设 BRD4-GATA4 模块控制 PGC-1α 和 β 的表达,
已知线粒体基因的主要转录调节因子,介导心肌细胞的表型
BRD4 损失(目标 3)。为了实现这些目标,我将结合我生成的新动物模型、标准
体外生化方法以及先进的分子生物学和生物信息学技术。我的长期
目标是对心力衰竭发病机制有更深入的分子了解,这可能会带来新的治疗方法。
我的研究生培训为我提供了心血管研究方面的重要经验,但是我的重点
是研究发育生物学的。我现在正致力于研究成人心肌细胞
体内平衡——这是我在心脏病学临床培训中产生的一个感兴趣的领域。我的研究导师有
在细胞和动物模型中使用尖端技术取得的有影响力的发现的长期记录
心血管疾病。格拉德斯通研究所/加州大学旧金山分校的研究环境非常优越,拥有
最先进的设备和研究人员做出突破性的发现。我组建了一个团队
成就卓著的导师和顾问指导我完成下一阶段的培训,走上通往成功之路
成为一名独立调查员。我的培训计划是专门为我提供指导而设计的
生物信息学、小鼠疾病建模以及分子先进技术方面的研究培训
生物学。除此之外,我还将获得管理研究小组所需的其他技能的经验,例如科学
通讯和实验室管理。完成研究并获得中概述的技能集
该提案将为我获得 R01 或同等资金以开始我的独立职业生涯做好准备
研究者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Arun Padmanabhan其他文献
Arun Padmanabhan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Arun Padmanabhan', 18)}}的其他基金
A BRD4-GATA4 module cooperatively regulates mitochondrial bioenergetic homeostasis in the adult heart
BRD4-GATA4 模块协同调节成人心脏中的线粒体生物能稳态
- 批准号:
10190564 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
A BRD4-GATA4 module cooperatively regulates mitochondrial bioenergetic homeostasis in the adult heart
BRD4-GATA4 模块协同调节成人心脏中的线粒体生物能稳态
- 批准号:
10655286 - 财政年份:2021
- 资助金额:
$ 15.09万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 15.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 15.09万 - 项目类别:
Operating Grants